These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 3560745)

  • 1. [Effect of inflammation and cholestasis on the metabolic function of the liver].
    Kogan AS; Nepomniashchikh VA
    Khirurgiia (Mosk); 1987 Feb; (2):79-81. PubMed ID: 3560745
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacometabolic capacity of the liver and the effect of pancreozymin in chronic hepatitis, chronic pancreatitis and diabetes mellitus].
    Geller LI; Griaznova MV; Bulgakova OS; Kozlova ZP
    Ter Arkh; 1982; 54(2):67-9. PubMed ID: 7071776
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hepatic metabolism of antipyrine in patients with acute pancreatitis].
    Lukaszyk A
    Przegl Lek; 1987; 44(2):273-6. PubMed ID: 3615930
    [No Abstract]   [Full Text] [Related]  

  • 4. [Fat metabolism and the liver].
    Gros H
    Med Klin; 1973 Aug; 68(32):1021-4. PubMed ID: 4582296
    [No Abstract]   [Full Text] [Related]  

  • 5. [Monooxigenase activity in liver diseases (study based on data of antipyrine metabolism)].
    Loginov AS; Bendikov EA; Kel'nia ZhA; Petrakov AV
    Ter Arkh; 1987; 59(2):84-9. PubMed ID: 3576485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neonatal cholestasis in Kashmiri children.
    Ahmad M; Jan M; Ali W; Shabir-ud-din ; Bashir C; Iqbal Q; Masood-ul-hassan
    JK Pract; 2000; 7(2):125-6. PubMed ID: 12349647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of benzonal on the drug-metabolizing function of the liver in pathological states].
    Nadzhimutdinov KN; Khakimov ZZ
    Farmakol Toksikol; 1988; 51(3):72-5. PubMed ID: 3410034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study of liver function by antipyrine clearance].
    Chrétien P; Boismare F
    LARC Med; 1983; 3(7):504-7. PubMed ID: 6645741
    [No Abstract]   [Full Text] [Related]  

  • 9. [The condition of the carbohydrate function of the liver in chronic biliary tract diseases in children].
    Koval' NI
    Pediatr Akus Ginekol; 1967; 2():19-21. PubMed ID: 5610520
    [No Abstract]   [Full Text] [Related]  

  • 10. [Metabolic disturbances in chronic diseases of the biliary tracts and liver].
    Kozlovskiĭ IV; Okorokov AN
    Vrach Delo; 1982 Aug; (8):22-4. PubMed ID: 6755904
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cholesterol metabolism disorders in digestive pathology. II].
    Rautureau J; Coste T; Rautureau M
    Arch Fr Mal App Dig; 1972 Aug; 61(8):497-506. PubMed ID: 4567365
    [No Abstract]   [Full Text] [Related]  

  • 12. [Correlation of the clearance of amylase and creatinine in acute pancreatitis and other pathologies].
    Morel C; Ferraina P; Valente A; Cervio R
    Acta Gastroenterol Latinoam; 1981; 11(1):171-93. PubMed ID: 6172947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of ultrasound on urea formation in the liver in chronic biliary tract diseases].
    Fedorov NE; Pitkevich ES; Kameko LT
    Vrach Delo; 1976 Apr; (4):114-7. PubMed ID: 1007174
    [No Abstract]   [Full Text] [Related]  

  • 14. [Activity of angiotensin converting enzyme I and levels of acid alpha glycoprotein in selected liver and biliary tract diseases].
    Podwysocki B; Simon K; Gładysz A
    Pol Tyg Lek; 1993 Mar 15-29; 48(11-13):268-70. PubMed ID: 8234040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cholate-forming liver function in chronic gastroduodenitis and biliary tract diseases].
    Loboda NI; Splavskiĭ OI
    Vrach Delo; 1980 Jan; (1):70-3. PubMed ID: 7376590
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of hepatic drug metabolism by (+)-cyanidanol-3 (Catergen) in chronic alcoholic liver disease.
    Pár A; Horváth T; Beró T; Kádas I; Pakodi F; Jávor T
    Acta Physiol Hung; 1984; 64(3-4):449-54. PubMed ID: 6152369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Drug metabolism in patients with liver disease (author's transl)].
    Richter E; Epping J; Fuchshofen-Röckel M; Heusler H; Zilly W
    Leber Magen Darm; 1980 Oct; 10(5):234-40. PubMed ID: 7464410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrahepatic cholestasis of pregnancy as an indicator of liver and biliary diseases: a population-based study.
    Ropponen A; Sund R; Riikonen S; Ylikorkala O; Aittomäki K
    Hepatology; 2006 Apr; 43(4):723-8. PubMed ID: 16557542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Properdin system and liver diseases].
    Reissmann G
    Z Gesamte Inn Med; 1970 Apr; 25(7):297-300. PubMed ID: 5521440
    [No Abstract]   [Full Text] [Related]  

  • 20. Liver function and medroxyprogesterone acetate elimination in man.
    Rautio A
    Biomed Pharmacother; 1984; 38(4):199-204. PubMed ID: 6498308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.